428 related articles for article (PubMed ID: 17397875)
1. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
2. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
3. Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis.
Izumo T; Kondo M; Nagai A
Eur Respir J; 2009 Dec; 34(6):1444-51. PubMed ID: 19460787
[TBL] [Abstract][Full Text] [Related]
4. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
5. Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Exp Lung Res; 2010 Jun; 36(5):292-301. PubMed ID: 20497024
[TBL] [Abstract][Full Text] [Related]
6. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
7. Effect of inhaled KP-496, a novel dual antagonist of the cysteinyl leukotriene and thromboxane A2 receptors, on a bleomycin-induced pulmonary fibrosis model in mice.
Kurokawa S; Suda M; Okuda T; Miyake Y; Matsumura Y; Ishimura M; Saito R; Nakamura T
Pulm Pharmacol Ther; 2010 Oct; 23(5):425-31. PubMed ID: 20457270
[TBL] [Abstract][Full Text] [Related]
8. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
10. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
11. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
Gao JM; Lu B
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
[TBL] [Abstract][Full Text] [Related]
12. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
13. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
15. [The effect of montelukast on airway remodeling and the expression of interleukins and transforming growth factor-beta2 mRNA].
Bai JW; Deng WW; Wu HC
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):524-8. PubMed ID: 15388000
[TBL] [Abstract][Full Text] [Related]
16. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
17. [Effects of cordyceps sinensi on bleomycin-induced pulmonary fibrosis in mice].
Wang SJ; Bai W; Wang CL; Dai Z
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(24):2623-7. PubMed ID: 18338602
[TBL] [Abstract][Full Text] [Related]
18. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
19. CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model.
Komura K; Yanaba K; Horikawa M; Ogawa F; Fujimoto M; Tedder TF; Sato S
Arthritis Rheum; 2008 Nov; 58(11):3574-84. PubMed ID: 18975313
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
